The DocUBuild tool grew out of the eMERGE network and helps institutions curate and manage genomic educational material for clinicians and patients alike.
Using exomes and linked electronic health records, the team uncovered a loss-of-function variant associated with decreased risk of liver disease and cirrhosis.
The health system hopes to pair the data with nearly three decades worth of electronic health records as well as medical histories provided by contributors.
In Science this week: analysis of DNA from ancient North Africans, and more.
Data aggregator InterSystems will integrate Edico Genome's DRAGEN CGIS into EHRs for easier test ordering and bidirectional data exchange.
Meditech, one of the oldest existing EHR companies, has staked out a role in supporting precision medicine with drug-gene interaction testing.
Irish rare disease research center FutureNeuro is partnering with software vendor Congenica to bring sequencing to the point of care for genetic epilepsies.
Following some major integration issues and other data challenges, Stanford is preparing to expand genomic medicine beyond rare diseases and cancer.
Amgen will use BC Platforms' tools and services to study data in multiple indications, including cardiovascular and bone diseases, hematological malignancies, and other cancers.
Organizers will not only collect genetic data on participants, but report back genetic risks via the country's national health information system.
American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.
A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.
Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.
In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.